SOURCE: slp3D

March 30, 2007 14:58 ET

ORLive Presents: Innovations in Transcatheter Valve Therapies: Less Invasive Approach to Treating Mitral and Aortic Valve Disease

Live Webcast: From NewYork-Presbyterian Hospital/Columbia University Medical Center: April 17, 2007 at 8:00 PM EDT (April 18, 2007 at 00:00 UTC)

NEW YORK, NY -- (MARKET WIRE) -- March 30, 2007 -- Discuss the latest clinical trials available for treating valve disease with panelist from NewYork-Presbyterian Hospital/Columbia University Medical Center live on www.OR-Live.com. The panel will discuss the EVEREST II trial; a prospective, randomized, multi-center phase II IDE clinical study to evaluate its percutaneous mitral valve repair system in the treatment of patients with moderate to severe or severe mitral regurgitation.

The panel will also discuss the initial feasibility study called REVIVAL, (Percutaneous Endovascular Implantation of Valves Trial) which involves the minimally invasive implantation of a heart valve in patients who are at high risk for open-heart surgery.

The live panel discussion will include renowned investigators from both trials. The webcast will be presented Tuesday, April 17, 2007 at 8 PM EDT from NewYork-Presbyterian Hospital/Columbia University Medical Center.

Panelists Dr. Jeffrey W. Moses, Dr. Martin B. Leon and Dr. William A. Gray will present the procedures and accept questions from the viewers during the live webcast.

Visit: http://www.or-live.com/nyp/1774 now to learn more and view a program preview. VNR http://www.or-live.com/rams/nep-1774-mkw.q.ram

Contact Information

  • Contact:

    Alex Fraser
    Director of Marketing
    slp3D, Inc / OR-Live™
    860-953-2900 x 214
    Email Contact